+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors



Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors



Magnetic Resonance in Medicine 46(2): 228-239



The combination of volumetric MRI and multivoxel localized MR spectroscopic imaging (MRSI) data provides the potential for quantifying variations in tissue morphology and function. These techniques have numerous applications for the evaluation of neurological diseases. While state-of-the-art whole-body MR scanners are able to acquire both types of data, there have been relatively few reports which have presented clinical applications of the technology. One of the reasons for this has been the need to develop software for reconstruction and reliable interpretation of 3D imaging and spectral data. In this article, we describe the strategy developed for quantitative analysis of combined MRI and MRSI examinations from patients with brain tumors and evaluate the key components of this procedure using both simulations and empirical data from phantoms, normal volunteers, and patients. Important factors are the use of volume or interleaved multislice anatomic images as a reference, the reconstruction and correction of the spectral data for frequency, phase, and baseline distortions and consideration of the characteristics of the coil, RF pulses used for spatial selection, and phase encoding procedures. These studies show that the metabolic parameters most critical for distinguishing tumor from normal and necrotic tissue were relative levels of choline and NAA. Levels of creatine and lactate were found to be variable, both in terms of their spatial distribution within individual lesions and between different patients.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010173307

Download citation: RISBibTeXText

PMID: 11477625

DOI: 10.1002/mrm.1183


Related references

Evaluation of optimal echo time for 1H-spectroscopic imaging of brain tumors at 3 Tesla. Journal of Magnetic Resonance Imaging 26(2): 427-431, 2007

Fast nosological imaging using canonical correlation analysis of brain data obtained by two-dimensional turbo spectroscopic imaging. Nmr in Biomedicine 21(4): 311-321, 2008

Magnetic resonance spectroscopic imaging associated with analysis of fluid in cystic brain tumors. Neurological Research 32(2): 194-197, 2010

Three-dimensional J-resolved H-1 magnetic resonance spectroscopic imaging of volunteers and patients with brain tumors at 3T. Magnetic Resonance in Medicine 58(5): 886-892, 2007

Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. Ajnr. American Journal of Neuroradiology 22(4): 604-612, 2001

Identification of primary tumors of brain metastases by infrared spectroscopic imaging and linear discriminant analysis. Technology in Cancer Research and Treatment 5(3): 291-298, 2006

Cerebral blood volume mapping by MR imaging in the initial evaluation of brain tumors. Journal of Neuroradiology. Journal de Neuroradiologie 29(2): 105-113, 2002

Independent component analysis to proton spectroscopic imaging data of human brain tumours. European Journal of Radiology 56(2): 160-164, 2005

Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data. Journal of Neurosurgery 98(1): 74-81, 2003

Neuroanatomical Diversity of Corpus Callosum and Brain Volume in Autism: Meta-analysis, Analysis of the Autism Brain Imaging Data Exchange Project, and Simulation. Biological Psychiatry 78(2): 126-134, 2015

Elliptical magnetic resonance spectroscopic imaging with GRAPPA for imaging brain tumors at 3 T. Magnetic Resonance Imaging 27(10): 1319-1325, 2009

Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI. Nmr in Biomedicine 12(3): 123-138, 1999

Neuroimaging in pediatric brain tumors: Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging. Ajnr. American Journal of Neuroradiology 23(2): 322-333, 2002

Evaluation of a semiautomatic 3D fusion technique applied to molecular imaging and MRI brain/frame volume data sets. Journal of Medical Systems 27(2): 141-156, 2003

Evaluation of combined bevacizumab plus irinotecan therapy in brain tumors using magnetic resonance imaging measures of relative cerebral blood volume. Magnetic Resonance in Medicine 68(4): 1266-1272, 2012